Weight-based dosing of enoxaparin with no maximum dose appears to result in similar therapeutic drug levels in obese patients compared to non-obese patients with acute venous thromboembolism (VTE). A five-year retrospective study compared outcomes in patients >100 kg treated with 1 mg/kg enoxaparin twice daily, patients <100 kg on the same dosing schedule and patients ...
Weight-based LMWH dosing without capping is OK for obese patients
By Mardi Chapman
6 Feb 2019